Fetal valproate syndrome with coronary arteriovenous fistula: a case report

2021 ◽  
pp. 1-3
Author(s):  
Alper Doğan ◽  
Ali Baykan ◽  
Cagdas Vural

Abstract Interestingly, our case presenting with coronary AV fistula firstly reported in the literature with fetal valproate syndrome. Although differential diagnosis is sometimes difficult, it can be diagnosed with detailed history, physical examination and appropriate laboratory tests. Fetal valproate syndrome can be prevented by discontinue of the valproic acid especially during first trimester of pregnancy.

2016 ◽  
Vol 2016 ◽  
pp. 1-4 ◽  
Author(s):  
Manisha Goyal ◽  
Ashok Gupta ◽  
Manish Sharma ◽  
Priyanshu Mathur ◽  
Naresh Bansal

Epilepsy is a common disorder and exposure to antiepileptic drugs during pregnancy increases the risk of teratogenicity. Older AEDs such as valproate and phenobarbital are associated with a higher risk of major malformations in the fetus than newer AEDs like lamotrigine and levetiracetam. Exposure to valproic acid during first trimester can result in fetal valproate syndrome (FVS), comprising typical facial features, developmental delay, and a variety of malformations such as neural tube defects, cardiac and genitourinary malformations, and limb defects. We are presenting an Indian case of FVS with major limb defects.


2011 ◽  
Vol 38 (S1) ◽  
pp. 190-190
Author(s):  
B. De Keersmaecker ◽  
A. Segaert ◽  
V. Dewulf ◽  
B. Denys ◽  
J. Thys

2004 ◽  
Vol 19 (10) ◽  
pp. 2401-2403 ◽  
Author(s):  
A. Esmans ◽  
J. Gerris ◽  
E. Corthout ◽  
P. Verdonk ◽  
S. Declercq

2003 ◽  
Vol 23 (2) ◽  
pp. 163-165 ◽  
Author(s):  
Edouard Kauffmann ◽  
Horatiu Roman ◽  
Georges Barau ◽  
Herv� Dumas ◽  
Annick Laffitte ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document